DTIL
Precision BioSciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.47
+1.36%Leverage
- Debt / equity
- 0.62x
- Net debt / equity
- -1.28x
- Debt / assets
- 0.22x
- Debt / EBITDA
- -0.56x
- Net debt / EBITDA
- 1.16x
Liquidity & coverage
- Current ratio
- 12.82x
- Quick ratio
- 12.82x
- Cash ratio
- 12.26x
- Interest coverage
- -27.55x
- EBITDA / interest
- -37.89x
- Working capital
- $84.4M
Cash & dividend
- FCF / debt
- -1.85x
- Cash flow / debt
- -1.85x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026